Dual Targeting of JAK and TNFα in Pediatric Patients with Severe Steroid-Resistant Graft-versus-Host Disease
-
By
-
Manon Queudeville
-
Jaspar Kloehn
-
Ysabel Alessa Schwietzer
-
Kai Lehmberg
-
Johanna Schrum
-
Ingo Müller
-
June 12, 2026
Clinical Scorecard: Dual Targeting of JAK and TNFα in Pediatric Patients with Severe Steroid-Resistant Graft-versus-Host Disease
At a Glance
| Category | Detail |
|---|
| Condition | |
| Key Mechanisms | |
| Target Population | |
| Care Setting | Specify if the study was conducted in a single center or multiple centers. |
Key Highlights
Guideline-Based Recommendations
Diagnosis
Management
Monitoring & Follow-up
- I
- n
- c
- l
- u
- d
- e
-
- s
- p
- e
- c
- i
- f
- i
- c
-
- p
- a
- r
- a
- m
- e
- t
- e
- r
- s
-
- f
- o
- r
-
- m
- o
- n
- i
- t
- o
- r
- i
- n
- g
-
- a
- d
- v
- e
- r
- s
- e
-
- e
- v
- e
- n
- t
- s
-
- r
- e
- l
- a
- t
- e
- d
-
- t
- o
-
- r
- u
- x
- o
- l
- i
- t
- i
- n
- i
- b
- .
Risks
Patient & Prescribing Data
Include potential side effects and management strategies for combination therapy.
Clinical Best Practices
Related Resources & Content
